Showing results (2151-2160 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Induction by an immunogenic immunomodulating agent of nonspecific T cell suppression of lymphocyte responsiveness in MLR but not of antibody productionC Reuben, D Halperin, S Ben-Efraim, et al.
Cancer Immunology, Immunotherapy : CII|April 13, 2018
Personalized cancer vaccines: adjuvants are important, tooCécile Gouttefangeas, Hans-Georg Rammensee
Cancer Immunology, Immunotherapy : CII|April 2, 2018
Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemiaFranziska Blaeschke, Dana Stenger, Theresa Kaeuferle, et al.
Cancer Immunology, Immunotherapy : CII|December 17, 2009
Patients with oral squamous cell carcinoma are characterized by increased frequency of suppressive regulatory T cells in the blood and tumor microenvironmentThaís Helena Gasparoto, Tatiana Salles de Souza Malaspina, Luciana Benevides, et al.
Cancer Immunology, Immunotherapy : CII|January 21, 2010
Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinomaMartin Pölcher, Michael Braun, Nicolaus Friedrichs, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2010
Comparison of AAV/IL-7 autocrine (T cell) versus paracrine (DC) gene delivery for enhancing CTL stimulation and functionChang-Xuan You, Yong Liu, Min Shi, et al.
Cancer Immunology, Immunotherapy : CII|January 7, 2010
CD34-based enrichment of genetically engineered human T cells for clinical use results in dramatically enhanced tumor targetingHåkan Norell, Yi Zhang, James McCracken, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trialR Obrist, J Schmidli, R Müller, et al.
Cancer Immunology, Immunotherapy : CII|April 30, 2017
High prevalence of antibodies reacting to mimotopes of Simian virus 40 large T antigen, the oncoprotein, in serum samples of patients affected by non-Hodgkin lymphomaElisa Mazzoni, Silvia Pietrobon, Miriam Bilancia, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2017
The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case seriesXizhi Wen, Ya Ding, Jingjing Li, et al.
Pageof 652